XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Deferred Stock
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Balance beginning of period (in shares) at Dec. 31, 2022   107,193          
Balance beginning of period at Dec. 31, 2022 $ 608,737 $ 10,719 $ 1,463,215 $ 5,182 $ 3,599,529 $ (77,796) $ (4,392,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 214,054       214,054    
Other comprehensive (loss) income, net of tax 1,181         1,181  
Repurchases of common stock, net (9,554)           (9,554)
Common stock issued under stock plans, including excess tax benefit (in shares)   128          
Common stock issued under stock plans, including excess tax benefit 12,753 $ 13 12,765 (25)      
Share-based compensation cost 13,930   13,923 7      
Balance end of period (in shares) at Mar. 31, 2023   107,321          
Balance end of period at Mar. 31, 2023 841,101 $ 10,732 1,489,903 5,164 3,813,583 (76,615) (4,401,666)
Balance beginning of period (in shares) at Dec. 31, 2022   107,193          
Balance beginning of period at Dec. 31, 2022 608,737 $ 10,719 1,463,215 5,182 3,599,529 (77,796) (4,392,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 438,290            
Other comprehensive (loss) income, net of tax 4,131            
Balance end of period (in shares) at Jun. 30, 2023   107,378          
Balance end of period at Jun. 30, 2023 1,093,861 $ 10,738 1,515,197 5,515 4,037,819 (73,665) (4,401,743)
Balance beginning of period (in shares) at Mar. 31, 2023   107,321          
Balance beginning of period at Mar. 31, 2023 841,101 $ 10,732 1,489,903 5,164 3,813,583 (76,615) (4,401,666)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 224,236       224,236    
Other comprehensive (loss) income, net of tax 2,950         2,950  
Repurchases of common stock, net (77)           (77)
Common stock issued under stock plans, including excess tax benefit (in shares)   57          
Common stock issued under stock plans, including excess tax benefit 10,289 $ 6 10,283        
Deferred stock activity 0   (345) 345      
Share-based compensation cost 15,362   15,356 6      
Balance end of period (in shares) at Jun. 30, 2023   107,378          
Balance end of period at Jun. 30, 2023 $ 1,093,861 $ 10,738 1,515,197 5,515 4,037,819 (73,665) (4,401,743)
Balance beginning of period (in shares) at Dec. 31, 2023 107,506 107,506          
Balance beginning of period at Dec. 31, 2023 $ 1,484,530 $ 10,751 1,569,565 5,530 4,444,571 (71,206) (4,474,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 235,579       235,579    
Other comprehensive (loss) income, net of tax (9,191)         (9,191)  
Repurchases of common stock, net (177,192)           (177,192)
Common stock issued under stock plans, including excess tax benefit (in shares)   161          
Common stock issued under stock plans, including excess tax benefit 20,780 $ 16 20,792 (28)      
Share-based compensation cost 14,400   14,392 8      
Balance end of period (in shares) at Mar. 31, 2024   107,667          
Balance end of period at Mar. 31, 2024 $ 1,568,906 $ 10,767 1,604,749 5,510 4,680,150 (80,397) (4,651,873)
Balance beginning of period (in shares) at Dec. 31, 2023 107,506 107,506          
Balance beginning of period at Dec. 31, 2023 $ 1,484,530 $ 10,751 1,569,565 5,530 4,444,571 (71,206) (4,474,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 438,877            
Other comprehensive (loss) income, net of tax $ (13,975)            
Balance end of period (in shares) at Jun. 30, 2024 107,686 107,686          
Balance end of period at Jun. 30, 2024 $ 1,580,253 $ 10,769 1,625,451 5,885 4,883,448 (85,181) (4,860,119)
Balance beginning of period (in shares) at Mar. 31, 2024   107,667          
Balance beginning of period at Mar. 31, 2024 1,568,906 $ 10,767 1,604,749 5,510 4,680,150 (80,397) (4,651,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 203,298       203,298    
Other comprehensive (loss) income, net of tax (4,784)         (4,784)  
Repurchases of common stock, net (208,246)           (208,246)
Common stock issued under stock plans, including excess tax benefit (in shares)   19          
Common stock issued under stock plans, including excess tax benefit 5,360 $ 2 5,358        
Deferred stock activity 0   (375) 375      
Share-based compensation cost $ 15,719   15,719        
Balance end of period (in shares) at Jun. 30, 2024 107,686 107,686          
Balance end of period at Jun. 30, 2024 $ 1,580,253 $ 10,769 $ 1,625,451 $ 5,885 $ 4,883,448 $ (85,181) $ (4,860,119)